Tag: Endovascular

ReCor Medical Announces FDA Approval Of IDE For Pivotal Study Of Paradise® Ultrasound Denervation System For Treatment Of Hypertension

PALO ALTO, Calif., July 2, 2018 /PRNewswire/ — ReCor Medical announced today that the US Food & Drug Administration approved the Company’s new pivotal study of the Paradise Ultrasound Denervation System for the treatment of hypertension: RADIANCE-II. Building upon the recent positive results of the Company’s RADIANCE-HTN SOLO study, RADIANCE-II will be […]

Intact Vascular Sponsors Symposium on Post-Angioplasty Dissections

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual NCVH Conference in New Orleans on May 31. Post-Percutaneous Transluminal Angioplasty (“PTA”) dissections […]

US Endovascular Enters Into An Exclusive Distribution Agreement with Lepu Medical – Expands Peripheral and AV Access Product Portfolio

EARTH CITY, MO. (PRWEB) APRIL 27, 2018 Guide Wires and Inflation Device Kits, will allow US Endovascular to further its goal of offering the highest quality peripheral endovascular devices at the lowest possible cost to AV Access Centers, OBL (Outpatient Based Labs) and Hospital Systems. This partnership will also allow Lepu […]

Mentice Acquires Endovascular Business from Medical Simulation Corporation

GOTHENBURG, Sweden–(BUSINESS WIRE)–Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation’s (MSC) Medical Products division. Mentice is the global leader of simulation-based performance solutions for endovascular therapies. Under the agreement, Mentice will acquire the assets of the MSC’s Medical […]

Aortica Reports Successful Results Of First 30 Fenestrated EVAR Patients Using Automated Case Planning Software

9/25/2017 8:56:46 AM BELLEVUE, Wash.–(BUSINESS WIRE)–Aortica Corp. today announced that Dr. Benjamin Starnes, Chief of Vascular Surgery at the University of Washington (UW), has reported successful results for the first 30 patients undergoing Fenestrated Endovascular Aneurysm Repair (FEVAR) planned and performed using Aortica’s AORTAFIT™ automated case planning software. The cases […]

Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability

OXFORDSHIRE, England–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new strategy to focus sales efforts in the UK, Japan and China, and reduce operating and manufacturing costs in order to […]

Heart Endovascular & Rhythm of Texas Begins First Commercial, FDA-Cleared, In-Patient Use of DABRA™ to Treat Peripheral Artery Disease

SAN ANTONIO–(BUSINESS WIRE)–Today, the Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, to use its groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease (PAD) in order to combat the growing rise of diabetic […]

Utah’s Merit Medical (MMSI) Prices $136.5 Million Offering

Merit Medical Announces Closing of Public Offering of Common Stock SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that […]